| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +0.09% | -0.40% | +0.49% | +0.49% | — |
| 14d | 4 | +50.00% | -2.78% | +0.75% | -3.53% | -3.53% | — |
| 30d | 4 | +50.00% | +2.37% | +4.42% | -2.04% | -2.04% | — |
| 60d | 4 | +50.00% | +1.63% | +0.84% | +4.81% | +4.81% | — |
| 90d | 4 | +50.00% | +0.87% | +4.77% | -3.90% | -3.90% | — |
| 180d | 4(2 pending) | +0.00% | +1.73% | +8.87% | -7.14% | -7.14% | — |
| 1y | 4(4 pending) | — | — | — | — | — | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 80 | $8.61 | $689 | 47,055 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASE VP, Finance and Controller | 865 | — | — | 47,224 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 310 | $8.61 | $2.7K | 46,914 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 221 | — | — | 3,087 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 865 | — | — | 12,119 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASE VP, Finance and Controller | 221 | — | — | 47,135 | Mar 20, 2026 | Mar 24, 2026 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 79 | $8.68 | $686 | 46,359 | Dec 20, 2025 | Dec 23, 2025 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 220 | — | — | 3,308 | Dec 20, 2025 | Dec 23, 2025 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASE VP, Finance and Controller | 220 | — | — | 46,438 | Dec 20, 2025 | Dec 23, 2025 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 310 | $8.68 | $2.7K | 46,218 | Dec 20, 2025 | Dec 23, 2025 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | PURCHASE VP, Finance and Controller | 866 | — | — | 46,528 | Dec 20, 2025 | Dec 23, 2025 ↗ | View → |
| FDMT 4D MOLECULAR THERAPEUTICS, INC. | SALE VP, Finance and Controller | 866 | — | — | 12,984 | Dec 20, 2025 | Dec 23, 2025 ↗ | View → |